Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)
BEIJING & NANJING, China, June 04, 2025--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) and Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. ("NJCTTQ") announced that NTB003 (formerly BCG009), a co-developed injectable drug candidate, has received the Investigational New Drug (IND) approval from the National Medical Products Administration (NMPA). The approved indication is Thyroid Eye Disease (TED).
About NTB003 Injection
NTB003 is a second-generation fully human anti-IGF-1R monoclonal antibody co-developed by Biocytogen and Nanjing Chia Tai Tianqing. Antibody discovery and optimization were completed by Biocytogen using its proprietary RenMab™ fully human antibody discovery platform, while Nanjing Chia Tai Tianqing was responsible for CMC process development, GLP-compliant toxicology studies, and IND application. Compared with first-generation approved anti-IGF-1R therapeutics, NTB003 demonstrates enhanced molecular affinity, improved druggability, and an extended half-life. In vitro studies have shown that NTB003 exerts potent signal-blocking activity and effectively inhibits the release of hyaluronic acid (HA), indicating strong potential for further clinical development.
Clinical studies of teprotumumab and other investigational anti-IGF-1R biologics have demonstrated that targeting IGF-1R can deliver significant clinical benefits. These agents have shown rapid onset of therapeutic response and favorable outcomes in reducing proptosis and diplopia, improving quality of life, and lowering clinical activity scores in patients with TED.
Nanjing Chia Tai Tianqing will lead the clinical development and commercialization of NTB003 in China, aiming to provide an improved therapeutic option for Chinese TED patients. Biocytogen will be responsible for the global out-licensing of the product outside China.
About Biocytogen
Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® (RenMab™/ RenLite®/ RenNano®/ RenTCR-mimic™ ) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR-mimic antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >1,000,000 fully human antibody sequences against over 1000 targets for worldwide collaboration. As of December 31, 2024, approximately 200 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and over 50 target-nominated RenMice® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco, San Diego), and Germany (Heidelberg). For more information, please visit http://en.biocytogen.com.cn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250602962332/en/
Contacts
Biocytogen Contacts Antibody assets and platforms: BD-Licensing@biocytogen.com Media: pr@bbctg.com.cn
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Black & Veatch Participates in Industry Dialogues, Identifies Viable Pathways to Deliver Asia's Energy Transition at Energy Asia 2025
KUALA LUMPUR, Malaysia, June 10, 2025--(BUSINESS WIRE)--Black & Veatch, a global leader in human critical infrastructure solutions, will share ways to adapt international best practices to accelerate Southeast Asia's energy transition at the Energy Asia 2025 conference, taking place June 16-18 at the Kuala Lumpur Convention Center here. "As geopolitical tensions rise and extreme heat waves become more prolonged, Malaysia and its Southeast Asian neighbors need energy transition solutions that will meet their economic and environmental targets. "Black & Veatch is committed to drawing on its extensive sustainable infrastructure experience to help the region meet its growing energy demands with low and no-carbon energy sources," said Jerin Raj, managing director, Asia Pacific, Black & Veatch. Deep collaborations with industry leaders from energy and other sectors, and knowledge transfer are part of that commitment. At the conference in Malaysia, Anand Pattani, vice president and managing director, International Energy Majors, Black & Veatch, will discuss how traditional refiners can adapt to remain competitive in a low-carbon world and the pathways most viable for the refining sector. Pattani will propose global strategies that can be adapted to overcome technical, regulatory, and financial barriers. Aligning with Malaysia's priorities to reduce carbon footprints, optimize resource efficiency, and promote sustainable development, Black & Veatch has supported power projects in Malaysia since the 1990s, from strategic decision-making to financial and resource commitments, implementation and execution. About Black & Veatch Black & Veatch is a 100-percent employee-owned global engineering, procurement, consulting and construction company with more than 100-years of innovation in sustainable infrastructure. Since 1915, we have helped our clients improve the lives of people around the world by addressing the resilience and reliability of our most important infrastructure and energy assets. Follow us on and on LinkedIn, Facebook, X (Twitter) and Instagram. View source version on Contacts Media Contact Information: EMILY CHIA | +65 6335 6623 | Media@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
Black & Veatch Participates in Industry Dialogues, Identifies Viable Pathways to Deliver Asia's Energy Transition at Energy Asia 2025
KUALA LUMPUR, Malaysia--(BUSINESS WIRE)-- Black & Veatch, a global leader in human critical infrastructure solutions, will share ways to adapt international best practices to accelerate Southeast Asia's energy transition at the Energy Asia 2025 conference, taking place June 16-18 at the Kuala Lumpur Convention Center here. 'As geopolitical tensions rise and extreme heat waves become more prolonged, Malaysia and its Southeast Asian neighbors need energy transition solutions that will meet their economic and environmental targets. 'Black & Veatch is committed to drawing on its extensive sustainable infrastructure experience to help the region meet its growing energy demands with low and no-carbon energy sources,' said Jerin Raj, managing director, Asia Pacific, Black & Veatch. Deep collaborations with industry leaders from energy and other sectors, and knowledge transfer are part of that commitment. At the conference in Malaysia, Anand Pattani, vice president and managing director, International Energy Majors, Black & Veatch, will discuss how traditional refiners can adapt to remain competitive in a low-carbon world and the pathways most viable for the refining sector. Pattani will propose global strategies that can be adapted to overcome technical, regulatory, and financial barriers. Aligning with Malaysia's priorities to reduce carbon footprints, optimize resource efficiency, and promote sustainable development, Black & Veatch has supported power projects in Malaysia since the 1990s, from strategic decision-making to financial and resource commitments, implementation and execution. About Black & Veatch Black & Veatch is a 100-percent employee-owned global engineering, procurement, consulting and construction company with more than 100-years of innovation in sustainable infrastructure. Since 1915, we have helped our clients improve the lives of people around the world by addressing the resilience and reliability of our most important infrastructure and energy assets. Follow us on and on LinkedIn, Facebook, X (Twitter) and Instagram.
Business Wire
an hour ago
- Business Wire
Mitsubishi Electric's ME Innovation Fund Invests in Carbon Credit Monitoring Startup Archeda
TOKYO--(BUSINESS WIRE)-- Mitsubishi Electric Corporation (TOKYO: 6503) announced today that its ME Innovation Fund has invested in Archeda, Inc., a Japan-based startup that uses satellite data to develop and provide monitoring and analysis tools for carbon credits. The carbon credit system enables companies and other entities to buy and sell greenhouse gas-reduction outcomes (reduced or sequestered volumes) as emissions-allowance credits. This is the eleventh investment that the fund has made to date. As global efforts toward achieving carbon neutrality gain momentum, carbon offsetting has emerged as an effective strategy. Under this concept, companies, etc. strive to reduce their greenhouse gas emissions as much as possible and then compensate for any remaining emissions by investing in sustainable projects that reduce or sequester an equivalent amount of greenhouse gases. In Japan, an increasingly active market is developing for nature-based carbon credits, including activities to manage, conserve and protect the natural environment. The demand for carbon offsets and nature-based credits in Japan is expected to rise significantly with the planned launch of a national emissions trading scheme in fiscal 2027. The scheme, which will apply to companies that emit over 100,000 tons of CO 2 annually, will set a cap on each company's CO 2 emissions and allow them to trade surplus or deficit emissions allowances. However, challenges remain, such as the lack of clarity regarding how credits will be issued, highlighting the urgent need for mechanisms to ensure the trustworthiness of carbon credits.
